Voluntary Recall of Robaxin 750 mg Due to Dosage Misprint
TUESDAY, Oct. 2, 2018 -- Endo Pharmaceuticals is voluntarily recalling two lots of Robaxin (methocarbamol tablets) 750 mg tablets (100-count bottles) due to incorrect dosage information. According to the recall notice, the products have incorrect...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Methocarbamol | Pharmaceuticals